IONS - Ionis Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IONS is currently covered by 20 analysts with an average price target of $98.38. This is a potential upside of $22.35 (73.48%) from yesterday's end of day stock price of $56.71.

Ionis Pharmaceuticals's activity chart (see below) currently has 342 price targets and 294 ratings on display. The stock rating distribution of IONS is 90.16% BUY, 1.64% SELL and 8.2% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 78.81% with an average time for these price targets to be met of 495.08 days.

Highest price target for IONS is $130, Lowest price target is $61, average price target is $98.38.

Most recent stock forecast was given by DAVID LEBOWITZ from BMO. First documented stock forecast 22-May-2014.

Best performing analysts who are covering IONS - Ionis Pharmaceuticals:

Yanan Zhu Akash Tewari Debjit Chattopadhyay Alethia Young Luca Issi

Currently out of the existing stock ratings of IONS, 55 are a BUY (90.16%), 1 are a SELL (1.64%), 5 are a HOLD (8.2%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 03-Sep-2026

$61

$2.91 (5.01%)

$60

Buy Since 04-Nov-2021

$86

$27.91 (48.05%)

$86

Buy Since 02-Aug-2026

$76

$17.91 (30.83%)

$80

1 months 5 days ago
(02-Aug-2026)

8/9 (88.89%)

$21.51 (39.48%)

195

3.91

Buy Since 07-May-2024

$95

$36.91 (63.54%)

$100

1 months 9 days ago
(29-Jul-2026)

3/5 (60%)

$41.72 (78.30%)

349

2.81

Buy Since 12-May-2020

$85

$26.91 (46.32%)

$100

1 months 26 days ago
(12-Jul-2026)

18/21 (85.71%)

$28.25 (49.78%)

920

1.25

Show more analysts

Please expand the browser size to see the chart

What is IONS (Ionis Pharmaceuticals) average time for price targets to be met?

On average it took 495 days for the stock forecasts to be reached, with an average price target met ratio of 78.81%.

Which analyst most recently updated their price target on IONS (Ionis Pharmaceuticals)?

David Lebowitz

Which analyst has the most public recommendations on IONS (Ionis Pharmaceuticals)?

David Lebowitz works at BMO and has 16 price targets and 14 ratings on IONS

Which analyst is the currently most bullish on IONS (Ionis Pharmaceuticals)?

Mani Foroohar with the highest potential upside of $70.91

Which analyst is the currently most reserved on IONS (Ionis Pharmaceuticals)?

Esther Rajavelu with the lowest potential downside of -$35.18

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?